UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(G) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTION 13 AND 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 0-26190
US Oncology, Inc.
(Exact name of registrant as specified in its charter)
10101 Woodloch Forest
The Woodlands, Texas 77380, (281) 863-1000
(Address, including zip code, and telephone number, including area code,
of registrant’s principal executive offices)
The Woodlands, Texas 77380, (281) 863-1000
(Address, including zip code, and telephone number, including area code,
of registrant’s principal executive offices)
9.125% Senior Secured Notes Due 2017
(Title of each class of securities covered by this Form)
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file
reports under section 13(a) or 15(d) remains)
(Titles of all other classes of securities for which a duty to file
reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1) | o | |
Rule 12g-4(a)(2) | o | |
Rule 12h-3(b)(1)(i) | þ | |
Rule 12h-3(b)(1)(ii) | o | |
Rule 15d-6 | o |
Approximate number of holders of record as of the certification or notice date: None
Pursuant to the requirements of the Securities Exchange Act of 1934, US Oncology, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
Date: February 17, 2011 | US ONCOLOGY, INC. | |||
By: | /s/ Willie C. Bogan | |||
Willie C. Bogan | ||||
Vice President and Secretary | ||||